RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 BP Reduction by Renal Denervation Maintained over 24 Months in the EnligHTN I Trial
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 18
SP 12
OP 13
DO 10.1177/155989771418006
UL http://mdc.sagepub.com/content/14/18/12.abstract
AB The EnligHTN renal denervation system reduced office blood pressure (BP) with no serious periprocedural adverse events over 24 months of follow-up. This article presents long-term data from the first-in-human Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients trial [EnligHTN I; NCT01438229].